Bigul

Allotment of 1.63 Crore Redeemable Preference Shares to Promoters and Promoters Group

Panacea Biotec Ltd has informed BSE that the Company had allotted 1,63,00,000 (One Crore Sixty Three Lac Only) 0.5%, Non-Convertible Cumulative Redeemable Preference Shares (NCCRPS) of Rs.10 (Rupees Ten) each at par aggregating to Rs. 16.30 (Rupees Sixteen Crore Thirty lac Only) on private placement basis to the promotes of the Company in pursuance of Special Resolution passed by the shareholders in their Extra-Ordinary General Meeting held on...
06-01-2015
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Dr. Rajesh Jain (on behalf of Promoters) has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
05-01-2015
Bigul

Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Soshil Kumar Jain HUF has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE
29-12-2014
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Panacea Biotec Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
29-12-2014
Bigul

Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Soshil Kumar Jain HUF has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE
26-12-2014
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Panacea Biotec Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
24-12-2014
Bigul

Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Soshil Kumar Jain (HUF) has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE
24-12-2014
Bigul

Panacea Biotec announces Collaboration with a leading International Pharmaceutical Company

Panacea Biotec Ltd has informed BSE that the Company has entered into collaboration with a leading International Pharmaceutical Company for the development and supply of an immunosuppressant generic product in USA.
24-12-2014
Bigul

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Panacea Biotec Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
23-12-2014
Bigul

Disclosures under Reg.13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Soshil Kumar Jain HUF has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE
23-12-2014
Next Page
Close

Let's Open Free Demat Account